Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PESDEX sedation trial for oesophageal interventions
2011-004206-19Phase 4Completed
- Sponsor
- AMC Health
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine, propofol and alfentanil in esophageal disease and esophageal cancer (2 arms), sponsored by AMC Health. Primary endpoints: Patient satisfaction during sedation, Endoscopist satisfaction during sedation and 3 more. Started Sep 2011; status: completed.
02
Drugs
dexmedetomidinepropofolalfentanil
03
Conditions
esophageal diseaseesophageal cancer
Beyond the preview
Go deeper on 2011-004206-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004206-19.